| Mechanism of anti-cancer effect of β-glucan on SH-SY5Y cell line AK Filiz, Z Joha, F Yulak ||| Bangladesh Journal of Pharmacology||| 16 (4), 122-128, 2021 | 11 | 2021 |
| Synthesis of diaryl urea derivatives and evaluation of their antiproliferative activities in colon adenocarcinoma M Gömeç, F Yulak, H Gezegen, M Özkaraca, K Sayin, H Ataseven Journal of Molecular Structure 1254, 132318, 2022 | 7 | 2022 |
| Anticancer activity of sinapic acid by inducing apoptosis in HT-29 human colon cancer cell line Ş Taştemur, L Hacısüleyman, Ö Karataş, F Yulak, H Ataseven Canadian Journal of Physiology and Pharmacology 101 (7), 361-368, 2023 | 6 | 2023 |
| The anticancer effect of cannabinoid 2 agonist L-759,633 on C6 and SH-SY5Y cell lines Z Joha, F Yulak, A Öztürk, B Şahin, Ş Yıldırım Turkish Journal of Science and Health 2 (3), 6-13, 2021 | 6 | 2021 |
| FGF-18 alleviates memory impairments and neuropathological changes in a rat model of Alzheimer's disease AC Ciltas, S Karabulut, B Sahin, AK Filiz, F Yulak, M Ozkaraca, O Karatas, ... Neuropeptides 101, 102367, 2023 | 3 | 2023 |
| Mechanism of anticancer effect of gambogic acid on gastric signet ring cell carcinoma Z Joha, A Öztürk, F Yulak, Ö Karataş, H Ataseven Medical Oncology 40 (9), 269, 2023 | 3 | 2023 |
| GSK461364A suppresses proliferation of gastric cancer cells and induces apoptosis D Ataseven, Ş Taştemur, F Yulak, S Karabulut, M Ergul Toxicology in Vitro 90, 105610, 2023 | 2 | 2023 |
| Levetiracetam Protects Against Glutamate-Induced Excitotoxicity in SH-SY5Y Cell Line AÇ Çiltaş, S Gündoğdu, F Yulak International Journal of Nature and Life Sciences 6 (2), 142-150, 2022 | 2 | 2022 |
| Unveiling the Protective Potential of Sugammadex against PTZ-Induced Epileptic Seizures in Mice: A Comprehensive Study on Oxidative Stress, Apoptosis, and Autophagy M Karademir, A Öztürk, F Yulak, M Özkaraca, AS Taskiran Neurochemical Journal 18 (2), 338-347, 2024 | | 2024 |
| Investigation of the Effect of Indatraline on Oxidative Damage Induced by Hydrogen Peroxide in C6 Glioma Cell Line F Yulak, B Üngür Cumhuriyet Science Journal 44 (4), 645-649, 2023 | | 2023 |
| Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line Z Keskin, F Yulak, H Terzi, M İNANIR Cumhuriyet Science Journal 44 (4), 635-639, 2023 | | 2023 |
| Mechanism of anticancer effect of ETP-45658, a PI3K/AKT/mTOR pathway inhibitor on HT-29 Cells F Yulak, AK Filiz, Z Joha, M Ergul Medical Oncology 40 (12), 341, 2023 | | 2023 |
| Investigation of The Antiproliferative Effect of Colchicine on SNU-1 Gastric Cancer Cells F Yulak Cumhuriyet Science Journal 44 (2), 263-267, 2023 | | 2023 |
| The effects of sugammadex on pentylenetetrazole-induced seizures in mice M Karademir, A Ozturk, F Yulak, M Ozkaraca, AS Taskiran | | 2023 |
| Death receptor-dependent apoptosis and cell cycle delay induced by bioymifi in human cervical cancer cells. A Altun, ZDŞ Inan, F Yulak Pakistan Journal of Pharmaceutical Sciences 35 (4), 2022 | | 2022 |
| Investigation of the potential antitumor activity of PLK1 inhibitor SBE13 in colon cancer cell line HT29 M Gömeç, F Yulak, M Ergül Cumhuriyet Medical Journal 44 (2), 218-222, 2022 | | 2022 |
| Seftriaksonun C6 Glioma Hücre Hattında Glutamat Eksitotoksisitesi Üzerine Etkisinin Araştırılması Z EKİCİ, F YULAK Health Sciences Student Journal, 2022 | | 2022 |
| Basic Science Research Articles S Karahan, E Ağadayı, N Karagöz, E Korkmaz, Ş Karagözoğlu, ... | | 2022 |
| TürkFen ve Sağlık Dergisi Z Joha, F Yulak, A Öztürk, B Şahin, Ş Yıldırım Turkish Journal of Science and Health 2 (3), 6-13, 2021 | | 2021 |
